WNT5B and acute myeloid leukemia: WNT5B was also shown to be highly expressed in EpCAM+ cells (leukemia stem cells) in acute myeloid leukemia (AML) and to associate with the resistance of EpCAMhigh myeloid leukemia cells to cytotoxic chemotherapy (Zheng et al., 2017).